Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Prospective Cohort Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece

NCT02713295 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02713295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02713295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Prospective Cohort Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
June 16, 2016
Completion date
April 19, 2019
Enrollment
273 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe plaque psoriasis